Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Neovascular Age-Related Macular Degeneration (nAMD)
Clinical trial register · United States · industry-sponsored

Neovascular Age-Related Macular Degeneration (nAMD) Trials in the USA, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9129 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 03 Nov 2026, 03:16 UTC
9129
Studies in scope
industry-sponsored, all four open statuses
4971
Recruiting now
open to new participants
2191
Lead sponsors
across recruiting studies
Top states
California 8 Arizona 7 Georgia 6 Illinois 6 Florida 6
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Neovascular Age-Related Macular Degeneration (nAMD) trials in the USA

11 of 9129 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
Ocular Therapeutix, Inc.
Phase 3
850
California, Connecticut, Florida, Maryland, South Carolina, Texas
2026-04-27
Recruiting
Adverum Biotechnologies, Inc.
Phase 3
534
Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Illinois
2026-03-16
Recruiting
4D Molecular Therapeutics
Phase 3
480
Arizona, California, Colorado, Florida, Georgia, Illinois, Indiana, Louisiana
2025-07-22
Not yet open
Rophibio, Inc.
Phase 3
434
Arizona, Arkansas, Pennsylvania, Tennessee, Texas
2025-07
Active, closed
Hoffmann-La Roche
Phase 4
274
California, Florida, Illinois, Massachusetts, Nevada, New Jersey, New Mexico, Tennessee
2025-03-14
Active, closed
Adverum Biotechnologies, Inc.
Phase 3
311
Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Illinois
2025-02-28
Active, closed
A Long-term Follow up Study of EXG102-031 in Patients With wAMD (Everest LTFU)
NCT06817343Neovascular Age-Related Macular Degeneration (nAMD), Neovascular (Wet) Age-related Macular Degeneration (AMD)
Exegenesis Bio
Phase 1
12
Nevada, Pennsylvania
2024-09-10
Active, closed
Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)
NCT05769153Neovascular Age-related Macular Degeneration (nAMD)
Alcon Research
Phase 1/2
139
Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois
2023-12-06
Active, closed
Ocugenix Corporation
Phase 1
24
Indiana, Texas
2023-11-01
By invitation
AbbVie
Phase 2
116
Arizona, California, Georgia, Maryland, Massachusetts, Minnesota, Nevada, New Mexico
2021-12-20
Active, closed
AbbVie
Phase 2
146
Arizona, California, Georgia, Illinois, Maryland, Massachusetts, Nevada, New Mexico
2020-08-25
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 3 November 2026. https://priyalifescience.com/clinical-trials-usa/condition/neovascular-age-related-macular-degeneration-namd

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,129 studies in total at the last sync on 03 Nov 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies listing the condition Neovascular Age-Related Macular Degeneration (nAMD).

How many Neovascular Age-Related Macular Degeneration (nAMD) trials are recruiting in the US?

3 of the 11 studies on this page are recruiting new participants as of the 03 Nov 2026, 03:16 UTC sync. A further 1 have not yet opened recruitment, 6 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Neovascular Age-Related Macular Degeneration (nAMD)), 11 studies
PhaseStudiesRecruitingShare
Phase 35345.5%
Phase 12018.2%
Phase 22018.2%
Phase 1/2109.1%
Phase 4109.1%

Most active sponsors

Lead sponsors with the most studies (Neovascular Age-Related Macular Degeneration (nAMD))
Lead sponsorStudiesRecruiting
AbbVie20
Adverum Biotechnologies, Inc.21
4D Molecular Therapeutics11
Alcon Research10
Exegenesis Bio10
Hoffmann-La Roche10
Ocugenix Corporation10
Ocular Therapeutix, Inc.11
Rophibio, Inc.10

Top states

Top states (Neovascular Age-Related Macular Degeneration (nAMD)), by number of studies with a site there
StateStudies
California8
Arizona7
Florida6
Georgia6
Illinois6
Colorado4
Connecticut4
Nevada4
Arkansas3
Maryland3
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.